TOP STORIES
respiratory
Asthma

In their own words: patients describe the benefits and limits of mAbs for severe asthma


Patients with severe asthma experience significant improvements in quality-of-life and participation in life with add-on monoclonal antibody therapies but there’s still more to be done. Semi-structured interviews with 20 Australian patients revealed four emergent themes - that life is just easier,...

Patients with severe asthma experience significant improvements in quality-of-life and participation in life with add-on monoclonal antibody therapies but there’s...

Read more